AKANKSHA SHARMA

Ms. AKANKSHA SHARMA

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Ceramics International
Verified
Journal Article
Closed access
AIAminul Islam
Aminul Islam
ASAKANKSHA SHARMA
AKANKSHA SHARMA
PSPushpender Singh
Pushpender Singh
NPNiranjan Pandit
Niranjan Pandit
AKAnup Kumar Keshri
Anup Kumar Keshri

28 June 2018 in Journal of Electronic Materials
Verified
Journal Article
Closed access
PDF file
BSBudhi Singh
Budhi Singh
ASAKANKSHA SHARMA
AKANKSHA SHARMA
SGSubhasis Ghosh
Subhasis Ghosh

13 March 2026 in Immuno
Verified
Journal Article
Open access
PDF file
TSTejas Yuvaraj Suryawanshi
Tejas Yuvaraj Suryawanshi
NRNeha Redkar
Neha Redkar
ASAKANKSHA SHARMA
AKANKSHA SHARMA
JMJyotsna Mishra
Jyotsna Mishra
SSSumit Saxena
Sumit Saxena
Shobha ShuklaShobha Shukla
Shobha Shukla
Neuroinflammation is a central hallmark of numerous neurological disorders, including Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and spinal cord damage. Its persistent and dysregulated nature not only accelerates neuronal loss but also impedes endogenous repair, posing a major challenge for effective therapeutic intervention. Recent advances in nanobiotechnology have opened transformative opportunities to modulate neuroinflammation with unprecedented precision while simultaneously supporting neural regeneration. This review highlights emerging nanomaterial-based strategies including lipid-based, polymeric, inorganic nanoparticles designed to traverse the blood–brain barrier (BBB), deliver anti-inflammatory agents, modulate immune cell behavior, and attenuate glial activation. Extending beyond nanoparticle-based delivery systems, recent advances also emphasize the integration of nanomaterials into biomimetic architectures to provide structural and functional cues for neural repair. We further summarize how these functional nanostructured scaffolds, such as extracellular matrix (ECM) mimetic, nanofibrous and conductive hydrogels, are being leveraged in neural tissue engineering to direct stem cell fate, promote axonal outgrowth, and rebuild damaged neuroarchitectures. Moreover, pharmacokinetics, biodistribution, safety, clinical trials, regulatory considerations and limitations of nanotherapeutics in neurodegenerative diseases are discussed. By outlining the current progress, mechanistic insights, and translational challenges, this review underscores the potential of nanobiotechnology-enabled therapeutics to revolutionize the treatment of neuroinflammatory conditions and advance next-generation neural repair technologies.